James V. Dyke Net Worth

The estimated Net Worth of James V. Dyke is at least $642 Thousand dollars as of 9 March 2017. James Dyke owns over 10,513 units of Psychemedics stock worth over $38,789 and over the last 14 years James sold PMD stock worth over $602,745.

James Dyke PMD stock SEC Form 4 insiders trading

James has made over 4 trades of the Psychemedics stock since 2012, according to the Form 4 filled with the SEC. Most recently James sold 10,513 units of PMD stock worth $216,147 on 9 March 2017.

The largest trade James's ever made was selling 10,513 units of Psychemedics stock on 9 March 2017 worth over $216,147. On average, James trades about 1,144 units every 63 days since 2010. As of 9 March 2017 James still owns at least 17,050 units of Psychemedics stock.

You can see the complete history of James Dyke stock trades at the bottom of the page.

What's James Dyke's mailing address?

James's mailing address filed with the SEC is C/O PSYCHEMEDICS CORPORATION, 125 NAGOG PARK, ACTON, MA, 01720.

Insiders trading at Psychemedics

Over the last 21 years, insiders at Psychemedics have traded over $2,633,903 worth of Psychemedics stock and bought 95,845 units worth $742,060 . The most active insiders traders include Peter Kamin, A Clinton Allen, and Raymond C Jr Kubacki. On average, Psychemedics executives and independent directors trade stock every 101 days with the average trade being worth of $18,935. The most recent stock trade was executed by Charles M Doucot on 17 August 2023, trading 12,700 units of PMD stock currently worth $59,182.

What does Psychemedics do?

psychemedics (nasdaq: pmd) is the world's leading drug testing company using hair for the detection of drugs of abuse. psychemedics has been successfully operating for 30 years and thousands of corporations worldwide currently rely on psychemedics’ patented hair analysis technology for their pre-employment and employee drug screening. psychemedics'​ clients include over 10% of the fortune 500, some of the largest police departments in america, federal reserve banks, and schools. for more information, visit the psychemedics website at www.psychemedics.com.

Complete history of James Dyke stock trades at Psychemedics

Psychemedics executives and stock owners

Psychemedics executives and other stock owners filed with the SEC include:

• Raymond Kubacki,
  Chairman of the Board, President, Chief Executive Officer
• Raymond C. Kubacki,
  Chairman, CEO & Pres
• Charles Doucot,
  Executive Vice President
• Michael Schaffer,
  Vice President - Laboratory Operations
• Charles M. Doucot IV,
  Exec. VP
• Dr. Michael I. Schaffer Ph.D.,
  VP of Laboratory Operations
• A. Clinton Allen,
  Independent Director
• Fred Weinert,
  Independent Director
• Walter Tomenson,
  Independent Director
• Harry Connick,
  Independent Director
• Patrick J. Kinney Jr.,
  Sec.
• Sarah Ashby,
  VP & Gen. Counsel
• Andrew Limbek,
  VP of Fin. & Controller
• Annette Baumgartner,
  Founder
• Dr. Werner A. Baumgartner Ph.D.,
  Founder
• Peter Kamin,
  Director
• Neil Lerner,
  VP - Finance
• James V. Dyke,
  Vice President - Sales
• Michael Weisenhoff,
  
• Raymond J Ruddy,
  Vice President/Controller
• Jonathan D Compton,
  Vice President - Marketing
• William R Thistle,
  Sr. VP and Gen. Counsel
• Peter C Monson,
  VP, Treas., CFO & Asst. Sec.
• Jennifer Chmieleski,
  Vice President, Controller
• Richard T Christoph,
  10% owner
• William Dausey,
  Vice President of Sales
• Robyn C Davis,
  Director
• Andrew Reynolds,
  Director
• Shannon Shoemaker,
  Chief Revenue Officer
• Darius G Nevin,
  Director
• Brian Hullinger,
  President & CEO
• Daniella Mehalik,
  Vice President - Finance